These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 6152500

  • 21. Beta-adrenergic blocking agents. Effect of chronic dosage on a fit, middle-aged man: a case study and review.
    Steinrauf LK, Schulz AR, Ryder KW, Brunn PW, Cook D, Judy W.
    Indiana Med; 1985 Jul; 78(7):600-4. PubMed ID: 2863304
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Combined alpha and beta adrenergic receptor blockade in the treatment of renal hypertension].
    Stummvoll HK.
    Wien Med Wochenschr Suppl; 1981 Jul; 69():14-6. PubMed ID: 6123200
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared.
    Walker JJ, Greer I, Calder AA.
    Postgrad Med J; 1983 Jul; 59 Suppl 3():168-70. PubMed ID: 6647203
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].
    Zech P, Pozet N, Sassard J, Vincent M.
    Nouv Presse Med; 1980 Mar 29; 9(15):1087-90. PubMed ID: 7008020
    [Abstract] [Full Text] [Related]

  • 27. A multicentre study of labetalol in hypertension. New Zealand Hypertension Study Group.
    N Z Med J; 1981 Apr 08; 93(681):215-8. PubMed ID: 7017511
    [Abstract] [Full Text] [Related]

  • 28. Labetalol.
    Carter BL.
    Drug Intell Clin Pharm; 1983 Oct 08; 17(10):704-12. PubMed ID: 6354658
    [Abstract] [Full Text] [Related]

  • 29. Labetalol: an alpha- and beta-adrenoceptor blocking drug.
    Michelson EL, Frishman WH.
    Ann Intern Med; 1983 Oct 08; 99(4):553-5. PubMed ID: 6137987
    [Abstract] [Full Text] [Related]

  • 30. [Are the theoretical drawbacks of beta-blocker treatment in pregnancy being confirmed? A review of the literature].
    Tcherdakoff P, Goupil-Colliard M.
    J Pharmacol; 1983 Oct 08; 14 Suppl 2():143-50. PubMed ID: 6138464
    [Abstract] [Full Text] [Related]

  • 31. [Treatment of hypertension with the alpha- and beta-adrenergic blockader trandat].
    Erina EV, Charyev KhE, Lediashova GA, Smolenskiĭ AV.
    Ter Arkh; 1983 Oct 08; 55(9):43-8. PubMed ID: 6314576
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A new alpha and beta receptor antagonist in general practice.
    Manderson WS.
    Practitioner; 1979 Jan 08; 222(1327):131-4. PubMed ID: 419044
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Treatment of arterial hypertension with labetalol. A polycentric study].
    G Ital Cardiol; 1982 Jan 08; 12(10):729-35. PubMed ID: 7182212
    [Abstract] [Full Text] [Related]

  • 36. Use of labetalol during anesthesia for pheochromocytoma removal.
    Van Stratum M, Levarlet M, Lambilliotte JP, Lignian H, de Rood M.
    Acta Anaesthesiol Belg; 1983 Dec 08; 34(4):233-40. PubMed ID: 6673473
    [Abstract] [Full Text] [Related]

  • 37. Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.
    Adam WR, Meagher EJ, Barter CE.
    Clin Exp Hypertens A; 1982 Dec 08; 4(8):1419-28. PubMed ID: 6126285
    [Abstract] [Full Text] [Related]

  • 38. Labetalol in essential hypertension.
    Breckenridge A, Orme M, Serlin MJ, Maciver M.
    Br J Clin Pharmacol; 1982 Jun 08; 13(1 Suppl):37S-39S. PubMed ID: 6124264
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Ergometric control in hypertension treatment with labetalol].
    Prohaska H, Honetz N.
    Wien Med Wochenschr Suppl; 1981 Jun 08; 69():20-2. PubMed ID: 6952661
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.